Slotnik Capital, LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1963764 DALLAS, TX

Position in RNA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,196,217

+$776,983 QoQ

Shares Held

237,637

+31.3% QoQ

Ownership

1.39%

of shares outstanding

% of Portfolio

1.16%

of 13F equity value

Holder Rank

#14

of 154 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Slotnik Capital, LLC holds $52,358,137 across 4 Biotechnology names. RNA ranks #3 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	260,740	$34,608,020
2	TECH	BIO-TECHNE Corp	206,000	$14,553,900
3	RNA	Atrium Therapeutics, Inc. This page	237,637	$3,196,217
4			210,000	$0

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,196,217	237,637	+31.3%	Shares	Sole	2026-08-13
2026-03-31	$2,419,234	180,945	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.